SEC Form 4 · accession 0001131096-16-000363
ATHENAHEALTH INC · ATHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John A Kane
Director
Period of report
Jul 27, 2016
Accepted (ET)
Jul 28, 2016 · 5:33 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001131096
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2016 | M | 2,875 | $15.27 | A | 10,708 | D | |
| Common StockF1,F2 | Jul 27, 2016 | S | 2,875 | $128.81 | D | 7,833 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $15.27 | Jul 27, 2016 | M | 2,875 | D | Jul 26, 2007 | Jul 26, 2017 | Common Stock | 2,875 | 6,875 | D |
Explanation of responses
- F1The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on February 25, 2015, in accordance with Rule 10b5-1.
- F2Represents a weighted average price. These shares were sold in multiple transactions at prices ranging from $128.21 to $129.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).